Sit Investment Associates Inc. Purchases 16,395 Shares of Xylem Inc. $XYL

Key Points

• Sit Investment Associates Inc. increased its stake in Xylem Inc. by 24.9% in the first quarter, acquiring 16,395 additional shares for a total holding worth $9.83 million.
• Xylem reported a quarterly earnings per share (EPS) of $1.26, beating the consensus estimate by $0.11, with revenue increasing 6.1% year-over-year.
• The company announced a $0.40 per share quarterly dividend to be paid on September 25th, representing an annualized yield of 1.1%.

Sit Investment Associates Inc. boosted its holdings in Xylem Inc. (NYSE:XYL - Free Report) by 24.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 82,275 shares of the industrial products company's stock after acquiring an additional 16,395 shares during the quarter. Sit Investment Associates Inc.'s holdings in Xylem were worth $9,829,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Valley National Advisers Inc. raised its stake in shares of Xylem by 84.9% during the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock valued at $26,000 after purchasing an additional 101 shares in the last quarter. Perkins Coie Trust Co acquired a new position in Xylem during the 1st quarter valued at about $27,000. Center for Financial Planning Inc. raised its position in shares of Xylem by 52.0% during the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock worth $32,000 after buying an additional 91 shares in the last quarter. Heck Capital Advisors LLC acquired a new stake in shares of Xylem in the 4th quarter worth approximately $36,000. Finally, Headlands Technologies LLC boosted its holdings in shares of Xylem by 90.6% in the first quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company's stock valued at $36,000 after acquiring an additional 145 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.

Xylem Stock Down 0.2%

Shares of NYSE:XYL traded down $0.2790 during trading on Wednesday, reaching $141.5510. 309,323 shares of the company traded hands, compared to its average volume of 1,466,721. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $145.33. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. The firm has a market cap of $34.45 billion, a P/E ratio of 36.77, a price-to-earnings-growth ratio of 2.44 and a beta of 1.11. The firm has a fifty day simple moving average of $133.35 and a 200 day simple moving average of $126.12.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The business had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. During the same period in the previous year, the company earned $1.09 EPS. The firm's revenue was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Thursday, August 28th. Xylem's dividend payout ratio is 41.56%.

Wall Street Analyst Weigh In

XYL has been the subject of a number of research reports. UBS Group increased their price target on Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a research note on Tuesday, August 5th. Citigroup restated a "buy" rating and issued a $152.00 price objective (up previously from $137.00) on shares of Xylem in a report on Monday, July 14th. Robert W. Baird lowered their target price on Xylem from $149.00 to $146.00 and set an "outperform" rating on the stock in a report on Wednesday, April 30th. JPMorgan Chase & Co. assumed coverage on shares of Xylem in a research report on Friday, May 30th. They issued an "overweight" rating and a $148.00 price target on the stock. Finally, Stifel Nicolaus upped their price objective on shares of Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research note on Friday, August 1st. Six analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $151.57.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.